Drug Information
| General Information | ||||||
|---|---|---|---|---|---|---|
| Drug ID |
DR01327
|
|||||
| Drug Name |
Abiraterone acetate
|
|||||
| Synonyms |
CB-7630; JNJ-212082; Zytiga
|
|||||
| Drug Type |
Small molecular drug
|
|||||
| Indication | Prostate cancer [ICD11: 2C82] | Approved | [1] | |||
| Therapeutic Class |
Anticancer Agents
|
|||||
| Structure |
|
 |
||||
| 3D MOL | 2D MOL | |||||
| Formula |
C26H33NO2
|
|||||
| Canonical SMILES |
CC(=O)OC1CCC2(C3CCC4(C(C3CC=C2C1)CC=C4C5=CN=CC=C5)C)C
|
|||||
| InChI |
InChI=1S/C26H33NO2/c1-17(28)29-20-10-12-25(2)19(15-20)6-7-21-23-9-8-22(18-5-4-14-27-16-18)26(23,3)13-11-24(21)25/h4-6,8,14,16,20-21,23-24H,7,9-13,15H2,1-3H3/t20-,21-,23-,24-,25-,26+/m0/s1
|
|||||
| InChIKey |
UVIQSJCZCSLXRZ-UBUQANBQSA-N
|
|||||
| CAS Number |
CAS 154229-18-2
|
|||||
| Pharmaceutical Properties | Molecular Weight | 391.5 | Topological Polar Surface Area | 39.2 | ||
| Heavy Atom Count | 29 | Rotatable Bond Count | 3 | |||
| Hydrogen Bond Donor Count | 0 | Hydrogen Bond Acceptor Count | 3 | |||
| XLogP |
5.2
|
|||||
| PubChem CID | ||||||
| ChEBI ID |
CHEBI:68639
|
|||||
| TTD Drug ID | ||||||
| DT(s) Transporting This Drug | OATP2B1 | Transporter Info | Organic anion transporting polypeptide 2B1 | Substrate | [2] | |
| References | ||||||
| 1 | Abiraterone acetate was approved by FDA. The official website of the U.S. Food and Drug Administration. (2019) | |||||
| 2 | The impact of statin use on the efficacy of abiraterone acetate in patients with castration-resistant prostate cancer. Prostate. 2017 May;77(13):1303-1311. | |||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.